On Friday the U. S. Drug Enforcement Administration (DEA) will publish in the Federal Register the Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II, as recommended by the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data.<br><br><a href="http://www.justice.gov/dea/divisions/hq/2014/hq082114.shtml">READ MORE ON THE US DEPARTMENT OF JUSTICE | DEA</a>
